Handelsbanken Fonder AB raised its position in shares of agilon health, inc. (NYSE:AGL – Free Report) by 47.9% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 75,000 shares of the company’s stock after purchasing an additional 24,300 shares during the quarter. Handelsbanken Fonder AB’s holdings in agilon health were worth $142,000 at the end of the most recent quarter.
Several other large investors also recently modified their holdings of the company. Oak Thistle LLC bought a new stake in shares of agilon health in the 4th quarter valued at $25,000. Ieq Capital LLC purchased a new position in agilon health during the 4th quarter worth $26,000. Point72 Asia Singapore Pte. Ltd. purchased a new position in agilon health during the third quarter worth about $28,000. First Citizens Bank & Trust Co. bought a new position in shares of agilon health in the fourth quarter valued at approximately $46,000. Finally, Pines Wealth Management LLC purchased a new stake in shares of agilon health during the 4th quarter valued at $51,000.
agilon health Price Performance
NYSE AGL opened at $2.98 on Tuesday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.29 and a quick ratio of 1.29. agilon health, inc. has a 1-year low of $1.50 and a 1-year high of $7.73. The stock has a market capitalization of $1.23 billion, a price-to-earnings ratio of -3.17 and a beta of 0.67. The business’s fifty day moving average price is $2.99 and its 200-day moving average price is $2.98.
Insiders Place Their Bets
Analysts Set New Price Targets
AGL has been the topic of several research analyst reports. Barclays dropped their price objective on agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research note on Monday, November 11th. Royal Bank of Canada raised their price objective on agilon health from $3.00 to $3.50 and gave the company an “outperform” rating in a research note on Wednesday, February 26th. Stifel Nicolaus boosted their target price on agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday, February 26th. Sanford C. Bernstein increased their target price on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Finally, Needham & Company LLC restated a “hold” rating on shares of agilon health in a research note on Wednesday, February 26th. Two equities research analysts have rated the stock with a sell rating, thirteen have issued a hold rating and two have assigned a buy rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $3.95.
Check Out Our Latest Research Report on AGL
agilon health Profile
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.
Featured Articles
- Five stocks we like better than agilon health
- What Are the U.K. Market Holidays? How to Invest and Trade
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- TSX Venture Exchange (Formerly Canadian Venture Exchange)
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- What Investors Need to Know About Upcoming IPOs
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Want to see what other hedge funds are holding AGL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for agilon health, inc. (NYSE:AGL – Free Report).
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.